CD4 and cancer: We found that SMARCD3 expression was positively correlated with the levels of monocytes, resting dendritic cells, M2 macrophages, and resting mast cells and negatively correlated with those of naive B cells, eosinophils, M1 macrophages, neutrophils, focal helper T cells, plasma cells, and activated memory CD4 T cells in certain cancers.